📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

The novel ATR inhibitor VE-821 increases sensitivity of pancreatic cancer cells to radiation and chemotherapy. (2012)

First Author: Prevo R

Attributed to: Molecular determinants of Radiosensitivity funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.4161/cbt.21093

PubMed Identifier: 22825331

Publication URI: http://europepmc.org/abstract/MED/22825331

Type: Journal Article/Review

Volume: 13

Parent Publication: Cancer biology & therapy

Issue: 11

ISSN: 1538-4047